Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 15 of 15 for “"HEPATORENAL SYNDROME"”.
-
Real-world evaluation of terlipressin use in advanced cirrhosis and its complications : prescribing patterns, predictors, and clinical outcomes in hepatorenal syndrome and esophageal variceal bleeding using the TriNetX Research Network
… Advanced cirrhosis is frequently complicated by hepatorenal syndrome (HRS) and esophageal variceal bleeding (EVB), both of which are associated with significant morbidity and mortality. Following FDA approval of terlipressin for HRS in September 2022, real-world evidence describing prescribing …
-
Η ΕΠΙΔΡΑΣΗ ΤΗΣ ΧΟΛΗΔΟΧΟΝΗΣΤΙΔΟΑΝΑΣΤΟΜΩΣΗΣ ΣΤΗΝ ΙΣΤΟΛΟΓΙΑ ΤΟΥ ΝΕΦΡΟΥ. (ΠΕΙΡΑΜΑΤΙΚΗ ΕΡΓΑΣΙΑ)
… ARE DIFFERENT FROM THE ONES OBSERVED ON THE HEPATORENAL SYNDROME ACCORDING TO THE BIBLIOGRAPHY. WE BELIEVE THAT THE CHOLEDOCHOPEPTIC ANASTOMOSIS IS RESPONSIBLE FOR THESE CHANGES ON THE RENAL PARENCHYMA DUE PROBABLY TO THE IMPAIRMENT OF THE BILE SECRETION AND FLOW INTO THEGUT.
-
Indikacijos, kontraindikacijos transjugulinio intrahepatinio portosisteminio šunto suformavimui /
… hydrothorax because it reduces clinical signs, hepatorenal syndrome due to observed improvement in kidney function. Improvement in oxygenation have been observed in hepatopulmonary syndrome. Shunt use is limited by its effects on systemic hemodynamics. It can exacerbate heart failure, pulmonary …
-
Preliminary comparison of major adverse outcomes in patients with nonalcoholic fatty liver disease initiated on second-line antihyperglycemic therapy
… ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, bleeding esophageal varices, or hepatic encephalopathy), hepatocellular carcinoma, major adverse cardiovascular events (i.e., myocardial infarction, stroke, bleeding event, or congestive heart failure), and death. Incidence …
-
Φαρμακευτική παρέμβαση στις αιμοδυναμικές διαταραχές της κίρρωσης του ήπατος
… have long been put forward in the treatment of hepatorenal syndrome, which is characterized by renal failure suggested to be mediated by extreme arterial vasodilatation and subsequent intense renal vasoconstriction. However, since arterial vasodilatation is a constant feature of cirrhosis, …
-
Relaxin as a therapeutic haemodynamic modulator in liver disease
INTRODUCTION: Hepatorenal syndrome (HRS) is a common complication of advanced cirrhosis with a high mortality rate and limited treatment options. Central to its pathogenesis is severe, but potentially reversible, renal vasoconstriction leading to functional renal failure. Current pharmacological …
-
Διερεύνηση της συσχέτισης της βακτηριδιακής υπερανάπτυξης του λεπτού εντέρου με την υπερδυναμική κυκλοφορία, την καρδιακή λειτουργία, τη νεφρική λειτουργία και την κλινική έκβαση σε ασθενείς με κίρρωση του ήπατος
… of infections, decompensation rupture (ascites, hepatorenal syndrome, spontaneous bacterial peritonitis, variceal bleeding, encephalopathy) and mortality. To achieve the goal, patients with cirrhosis and a history of ascites who are monitored by the outpatient hepatology clinics of the University …
-
Μελέτη της συχνότητας, της φυσικής πορείας και θεραπευτικής ανταπόκρισης των επιπλοκών της κιρρώσεως
… those fulfilling the classic hepatopulmonary syndrome (HPS) criteria, correlate with clinical parameters and evaluate the survival of patients with HPS compared to those without HPS, (3) to compare the prognostic accuracy of ALBI, MELD, MELDNa, Child-Pugh and the corrected for Creatinine …
-
Φυσική ιστορία της αλκοολικής κίρρωσης στη Βορειοδυτική Ελλάδα: εμπειρία ενός κέντρου
… including decompensation, refractory ascites, hepatorenal syndrome, bacterial infections, hepatocellular carcinoma and death in relation to alcohol use and ascertained predictors of liver-related outcomes. Results: At baseline, 190 patients had compensated and 250 patients decompensated …
-
Extrakorporale Leberunterstützung bei Patienten mit akutem und akut-auf-chronischem Leberversagen unter besonderer Berücksichtigung von Patienten mit einem hepatorenalen Syndrom
Einleitung: Das hepatorenale Syndrom (HRS) ist eine schwerwiegende Komplikation bei fortgeschrittener Leberfunktionsstörung mit hoher Letalität. Trotz aufwendiger intensivmedizinischer Behandlung ist eine irreversible Schädigung der Leber häufig. Allerdings ist eine Regeneration der Leberfunktion …
-
Einfluss des A1-Adenosin-Rezeptorantagonisten SLV329 auf die Nierenfunktion im Modell der Thioacetamid-induzierten Leberzirrhose der Ratte
Hintergrund - Das hepatorenale Syndrom (HRS) ist primär eine funktionelle Niereninsuffizienz bei einer fortgeschrittenen Lebererkrankung. Die jährliche Inzidenz des HRS beträgt bei Patienten mit dekompensierter Zirrhose 8%. Häufig kommt es bei Zirrhotikern aufgrund der Aszitestherapie mit Diuretika …
-
In vitro selection and characterization of mono-, di-, and trivalent metal-dependent DNAzymes and their sensing applications
… in several other health conditions such as syndrome of inappropriate antidiuretic hormone secretion, hepatorenal syndrome, hypertension and different types of hyponatremia and hypernatremia. Two parallel in vitro selections were carried out to expand capability of DNAzymes in cleaving a …
-
Novel mechanisms and biomarkers in alcohol-induced organ injury.
Background. Ethanol (EtOH) consumption is known to affect multiple organs; this is unsurprising, as the concentration of EtOH in the blood at relevant doses reaches the millimolar range. The overarching goal of this dissertation was to elucidate mechanisms of alcohol-induced organ injury, …
-
Διαστολική δυσλειτουργία της αριστερής κοιλίας στην κίρρωση: συχνότητα, διερεύνηση της συσχέτισης με την συστολική λειτουργία, την νεφρική λειτουργία και την κλινική έκβαση και ο ρόλος της ενδοτοξιναιμίας και των β-αποκλειστών
… LVDD on the occurrence of decompensating events, hepatorenal syndrome(HRS), and liver-related survival also remains unclear. The treatment of LVDD is currently unknown. Recent data suggested that the β-blocker carvedilol might improve LVDD in patients with cirrhosis. Objective: The current study …
-
Complications of portal hypertension: clinical studies
… predominantly due to alcohol and the metabolic syndrome. The development of portal hypertension occurs in almost 90% of patients with cirrhosis. It marks the transitin from compensated to decompensated disease, it is the pathophysiological hallmark of cirrhosis related complica4ons, and is the …